Attached files

file filename
8-K - FORM 8-K - AMERICAN VANGUARD CORPd347487d8k.htm

Exhibit 99.1

 

LOGO

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS FIRST QUARTER 2012 RESULTS

Performance reflects growing demand for AMVAC’s granular soil insecticide franchise

Newport Beach, CA – May 3, 2012 – American Vanguard Corporation (NYSE:AVD), today announced financial results for the first quarter ended March 31, 2012.

Fiscal 2012 First Quarter Financial Highlights – versus Fiscal 2011 First Quarter

 

   

Net sales of $87.3 million, compared with $66.0 million, an increase of 32%.

 

   

Net income of $8.7 million, compared with $5.0 million, an increase of 74%.

 

   

Earnings per diluted share were $0.31, compared with $0.18, an increase of 72%.

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “Our first quarter 2012 business performance reflects positive conditions in the U.S. agricultural sector and was driven largely by the growing demand for our portfolio of granular soil insecticides. Gross profit margins rose to 43% as we achieved improved overall factory utilization rates. Operating expenses as a percentage of sales were held to 26%, despite higher regulatory expenses and freight costs that kept pace with our expanding export business. Stronger sales, improved gross margins and operating expense management enabled us to improve our bottom line significantly.”

Mr. Wintemute continued, “We are seeing renewed demand for the use of granular soil insecticides in the U.S. corn market, as growers combat strong pest pressure from both primary and secondary insects. The use of our corn soil insecticides in conjunction with genetically modified seeds as part of an integrated pest management program provides the most comprehensive defense against the full range of soil insects and can enhance harvest yields. American Vanguard has the largest offering of corn soil insecticides along with the most advanced, closed delivery equipment for safely and efficiently dispensing these products.”

Mr. Wintemute concluded, “Our performance during the quarter serves to validate our long-standing belief that conventional chemistry is an essential part of integrated pest management. We are, of course, pleased with these results and look forward to giving additional color during our earnings call on the period.”


Conference Call

Eric Wintemute, Chairman & CEO and David Johnson, CFO, will conduct a conference call focusing on the financial results at 12:00 pm ET / 9:00 am PT on Thursday, May 3, 2012. Interested parties may participate in the call by dialing (201) 493-6744. Please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and the control of public and animal health pests. American Vanguard is included in the Russell 2000® & Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in the conference call referenced in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

CONTACT:   
American Vanguard Corporation    The Equity Group Inc.
William A. Kuser, Director of Investor Relations    www.theequitygroup.com
(949) 260-1200    Lena Cati (212) 836-9611
williamk@amvac-chemical.com    Lcati@equityny.com


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(In thousands, except per share data)

(Unaudited)

 

     For the three months
ended March 31
 
     2012     2011  

Net sales

   $ 87,255      $ 66,033   

Cost of sales

     49,877        39,123   
  

 

 

   

 

 

 

Gross profit

     37,378        26,910   

Operating expenses

     22,976        17,723   
  

 

 

   

 

 

 

Operating income

     14,402        9,187   

Interest expense

     735        806   

Interest capitalized

     (36     (58

Extinguishment of debt

     —          546  
  

 

 

   

 

 

 

Income before income tax

     13,703        7,893   

Income tax expense

     4,969        2,881   
  

 

 

   

 

 

 

Net income

     8,734        5,012   

Change in fair value of interest rate swaps

     22        (246

Foreign currency translation adjustment

     542        237   
  

 

 

   

 

 

 

Comprehensive income

   $ 9,298      $ 5,003   
  

 

 

   

 

 

 

Earnings per common share—basic

   $ .32      $ .18   
  

 

 

   

 

 

 

Earnings per common share—assuming dilution

   $ .31      $ .18   
  

 

 

   

 

 

 

Weighted average shares outstanding—basic

     27,624        27,596   
  

 

 

   

 

 

 

Weighted average shares outstanding—assuming dilution

     28,299        27,851   
  

 

 

   

 

 

 

As reported at the earnings call and set forth in the financial statements in the Company’s form 10-K for the period ended December 31, 2011, the company has reclassified immaterial program costs from operating expenses to net sales for all reporting periods. The figures in the prior year statement, presented here, reflect this reclassification.


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

ASSETS (note 7)

 

     Mar. 31,
2012
    Dec. 31,
2011
 
     (Unaudited)     (Note)  

Current assets:

    

Cash

   $ 14,732      $ 35,085   

Receivables:

    

Trade, net of allowance for doubtful accounts of $397 and $340, respectively

     98,625        68,611   

Other

     1,473        1,187   
  

 

 

   

 

 

 
     100,098        69,798   
  

 

 

   

 

 

 

Inventories

     74,667        71,068   

Prepaid expenses

     3,399        2,311   

Income taxes receivable

     —          203   
  

 

 

   

 

 

 

Total current assets

     192,896        178,465   

Property, plant and equipment, net

     43,039        39,273   

Intangible assets

     114,703        116,189   

Other assets

     5,012        5,214   
  

 

 

   

 

 

 
   $ 355,650      $ 339,141   
  

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current liabilities:

    

Current installments of long-term debt

   $ 14,896      $ 14,460   

Current installments of other liabilities

     1,134        1,038  

Accounts payable

     24,381        23,214   

Deferred revenue

     —          7,571   

Accrued program costs

     45,383        25,910   

Accrued expenses and other payables

     6,032        6,832   

Income taxes payable

     3,479        —     
  

 

 

   

 

 

 

Total current liabilities

     95,305        79,025   

Long-term debt, excluding current installments

     43,527        51,917   

Other liabilities, excluding current installments

     5,774        5,955   

Deferred income taxes

     15,172        15,172   
  

 

 

   

 

 

 

Total liabilities

     159,778        152,069   
  

 

 

   

 

 

 

Commitments and contingent liabilities

    

Stockholders’ equity:

    

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

     —          —     

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 30,083,066 shares at March 31, 2012 and 29,845,047 shares at December 31, 2011

     3,009        2,985   

Additional paid-in capital

     46,824        45,966   

Accumulated other comprehensive loss

     (1,686     (2,250

Retained earnings

     150,878        143,524   
  

 

 

   

 

 

 
     199,025        190,225   

Less treasury stock, at cost, 2,260,996 shares at March 31, 2012 and at December 31, 2011

     (3,153     (3,153
  

 

 

   

 

 

 

Total stockholders’ equity

     195,872        187,072   
  

 

 

   

 

 

 
   $ 355,650      $ 339,141   
  

 

 

   

 

 

 

Note: The balance sheet at December 31, 2011 has been derived from the audited financial statements at that date.


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

For The Three Months Ended March 31, 2012 and 2011

(Unaudited)

 

Increase (decrease) in cash

   2012     2011  

Cash flows from operating activities:

    

Net income

   $ 8,734      $ 5,012   

Adjustments to reconcile net income to net cash used in operating activities:

    

Depreciation and amortization of fixed and intangible assets

     3,469        3,251   

Amortization of other long term assets

     682        1,253   

Amortization of discounted liabilities

     198        388  

Stock-based compensation

     422        523   

Tax benefit from exercise of stock options

     (43     —     

Changes in assets and liabilities associated with operations:

    

Increase in net receivables

     (30,300     (29,900

Increase in inventories

     (3,599     (3,243

Increase in prepaid expenses and other assets

     (1,568     (1,988

Decrease in income tax receivable/payable, net

     3,725        8,133   

Increase in accounts payable

     1,188        7,703   

Decrease in deferred revenue

     (7,571     (5,533

Increase in other liabilities

     17,065        3,896   
  

 

 

   

 

 

 

Net cash used in operating activities

     (7,598     (10,505
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Capital expenditures

     (5,718     (910
  

 

 

   

 

 

 

Net cash used in investing activities

     (5,718     (910
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Net (repayments) borrowings under line of credit agreement

     —          (7,300

Principal payments on long-term debt

     (2,000     (2,004

Tax benefit from exercise of stock options

     43        —     

Borrowings on long-term debt

     —          20,063   

Decrease in other notes payable

     (6,035     —     

Proceeds from the issuance of common stock (sale of stock under ESPP and exercise of stock option)

     417        550   
  

 

 

   

 

 

 

Net cash (used in) provided by financing activities

     (7,575     11,309   
  

 

 

   

 

 

 

Net (decrease) in cash

     (20,891     (106

Cash and cash equivalents at beginning of period

     35,085        1,158   

Effect of exchange rate changes on cash

     538        222   
  

 

 

   

 

 

 

Cash and cash equivalents as of March 31

   $ 14,732      $ 1,274